Literature DB >> 22258434

Risk factors for hepatocellular carcinoma in patients with chronic liver disease: a case-control study.

Nghi B Ha1, Nghiem B Ha, Aijaz Ahmed, Walid Ayoub, Tami J Daugherty, Ellen T Chang, Glen A Lutchman, Gabriel Garcia, Allen D Cooper, Emmet B Keeffe, Mindie H Nguyen.   

Abstract

The majority of data on risk factors (RFs) for hepatocellular carcinoma (HCC) comes from studies involving populations without underlying liver disease. It is important to evaluate RFs for HCC in patients with chronic liver disease since HCC rarely occurs in those without underlying liver disease. We conducted a hospital-based case-control study of 259 incident HCC cases and 781 controls by convenience sampling between 02/2001 and 12/2009 from the liver clinic at Stanford University Medical Center. The study population was 41% White, 14% Hispanic, 3% African American, 40% Asian American, and 2% other race/ethnicity. RFs were examined through medical records and an in-person questionnaire. Alcohol and tobacco use was calculated by cumulative grams of alcohol or cumulative pack(s) of cigarette consumed over one's lifetime. Diabetes mellitus (DM) was defined by random glucose level of ≥200 mg/dL. RFs were evaluated using multivariate logistic regression. Independent predictors of HCC risk, after mutual adjustment and additional control for alcohol use, etiology of liver diseases, and DM, included age >40 (OR = 8.5 [2.6-28.3]), male gender (OR = 3.5 [2.2-5.8]), presence of cirrhosis (OR = 2.8 [1.6-4.9]), Asian ethnicity (OR = 2.8 [1.8-4.6]), AFP > 50 (OR = 4.2 [2.6-6.8]), and cumulative lifetime tobacco use of >11,000 packs (OR = 1.7 [1.0-2.9]). Heavy prolonged cigarette smoking, but not alcohol use, was a significant independent predictor for HCC in patients with underlying liver disease. Besides older age, male gender, presence of cirrhosis, and elevated AFP, Asian ethnicity and heavy cumulative tobacco use are strong independent predictors of HCC.

Entities:  

Mesh:

Year:  2012        PMID: 22258434     DOI: 10.1007/s10552-012-9895-z

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  13 in total

1.  Potential contributions of the tobacco nicotine-derived nitrosamine ketone (NNK) in the pathogenesis of steatohepatitis in a chronic plus binge rat model of alcoholic liver disease.

Authors:  Valerie Zabala; Ming Tong; Rosa Yu; Teresa Ramirez; Emine B Yalcin; Silvia Balbo; Elizabeth Silbermann; Chetram Deochand; Kavin Nunez; Stephen Hecht; Suzanne M de la Monte
Journal:  Alcohol Alcohol       Date:  2015-01-24       Impact factor: 2.826

Review 2.  Methodological assessment of HCC literature.

Authors:  G Daniele; N Costa; V Lorusso; J Costa-Maia; I Pache; M Pirisi
Journal:  Ann Oncol       Date:  2013-04       Impact factor: 32.976

3.  PIN1 genetic polymorphisms and the susceptibility of HBV-related hepatocellular carcinoma in a Guangxi population.

Authors:  Li Huang; Zhuning Mo; Xianjun Lao; Xiaolian Zhang; Yanqiong Liu; Jingzhe Sui; Xue Qin; Shan Li
Journal:  Tumour Biol       Date:  2015-12-07

4.  Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.

Authors:  Agostino Colli; Tin Nadarevic; Damir Miletic; Vanja Giljaca; Mirella Fraquelli; Davor Štimac; Giovanni Casazza
Journal:  Cochrane Database Syst Rev       Date:  2021-04-15

5.  Association between catalase gene polymorphisms and risk of chronic hepatitis B, hepatitis B virus-related liver cirrhosis and hepatocellular carcinoma in Guangxi population: a case-control study.

Authors:  Yanqiong Liu; Li Xie; Jiangyang Zhao; Xiuli Huang; Liuying Song; Jingrong Luo; Liping Ma; Shan Li; Xue Qin
Journal:  Medicine (Baltimore)       Date:  2015-04       Impact factor: 1.889

6.  Risk of primary liver cancer associated with gallstones and cholecystectomy: a meta-analysis.

Authors:  Yanqiong Liu; Yu He; Taijie Li; Li Xie; Jian Wang; Xue Qin; Shan Li
Journal:  PLoS One       Date:  2014-10-07       Impact factor: 3.240

7.  CBX6 overexpression contributes to tumor progression and is predictive of a poor prognosis in hepatocellular carcinoma.

Authors:  Hao Zheng; Wei-Hua Jiang; Tao Tian; Hai-Song Tan; Ying Chen; Guang-Lei Qiao; Jun Han; Sheng-Yu Huang; Yuan Yang; Shuai Li; Zhen-Guang Wang; Rong Gao; Hao Ren; Hao Xing; Jun-Sheng Ni; Lin-Hui Wang; Li-Jun Ma; Wei-Ping Zhou
Journal:  Oncotarget       Date:  2017-03-21

8.  Correlation analysis of preoperative serum alpha-fetoprotein (AFP) level and prognosis of hepatocellular carcinoma (HCC) after hepatectomy.

Authors:  Wen-jun Ma; Hai-yong Wang; Li-song Teng
Journal:  World J Surg Oncol       Date:  2013-08-27       Impact factor: 2.754

Review 9.  Development and novel therapeutics in hepatocellular carcinoma: a review.

Authors:  Pravinkumar Vishwanath Ingle; Sarah Zakiah Samsudin; Pei Qi Chan; Mei Kei Ng; Li Xuan Heng; Siu Ching Yap; Amy Siaw Hui Chai; Audrey San Ying Wong
Journal:  Ther Clin Risk Manag       Date:  2016-03-16       Impact factor: 2.423

10.  Association of Paraoxonase 1 Gene Polymorphisms With the Risk of Hepatitis B Virus-related Liver Diseases in a Guangxi Population: A Case-control Study.

Authors:  Xianjun Lao; Xiaogang Wang; Yanqiong Liu; Yu Lu; Dongmei Yang; Minyan Liu; Xiaolian Zhang; Chengzhi Rong; Xue Qin; Shan Li
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.